Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Johnston, C. Ward, R. Kopito (1998)
Aggresomes: A Cellular Response to Misfolded ProteinsThe Journal of Cell Biology, 143
W. Matsuyama, M. Nakagawa, T. Moritoyo, H. Takashima, F. Umehara, K. Hirata, M. Suehara, M. Osame (2001)
Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant Connexin 32 (GJB1)Journal of Human Genetics, 46
J. Grinspan, Markella Coulalaglou, J. Beesley, David Carpio, S. Scherer (1998)
Maturation‐dependent apoptotic cell death of oligodendrocytes in myelin‐deficient ratsJournal of Neuroscience Research, 54
S. Bort, E. Nelis, V. Timmerman, T. Sevilla, A. Cruz‐Martínez, F. Martínez, J. Millán, J. Arpa, J. Vílchez, F. Prieto, C. Broeckhoven, F. Palau (1997)
Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsiesHuman Genetics, 99
A. Gow, V. Friedrich, R. Lazzarini (1994)
Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transportJournal of Neuroscience Research, 37
Melvin Greer (1970)
Neuromuscular Diseases of Infancy and ChildhoodNeurology, 20
Patricia Martin, E. Mambetisaeva, D. Archer, C. George, W. Evans (2000)
Analysis of Gap Junction Assembly Using Mutated Connexins Detected in Charcot—Marie—Tooth X‐Linked DiseaseJournal of Neurochemistry, 74
E. Kamsteeg, T. Wormhoudt, J. Rijss, C. Os, P. Deen (1999)
An impaired routing of wild‐type aquaporin‐2 after tetramerization with an aquaporin‐2 mutant explains dominant nephrogenic diabetes insipidusThe EMBO Journal, 18
(1996)
CNS abnormalities in a family with a connexin32 mutation and peripheral neuropathy
C. Castro, J. Gómez-Hernandez, K. Silander, L. Barrio (1999)
Altered Formation of Hemichannels and Gap Junction Channels Caused by C-Terminal Connexin-32 MutationsThe Journal of Neuroscience, 19
T. Stauffer, D. Guerini, E. Carafoli (1995)
Tissue distribution of the four gene products of the plasma membrane Ca2+ pump. A study using specific antibodies.The Journal of biological chemistry, 270 20
L. Musil, D. Goodenough (1993)
Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ERCell, 74
M. Bähr, F. Andres, Vincent Timmerman, M. Nelis, C. Broeckhoven, Johannes Dichgans (1999)
Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 geneJournal of Neurology, Neurosurgery & Psychiatry, 66
J. Li, E. Hertzberg, J. Nagy (1997)
Connexin32 in oligodendrocytes and association with myelinated fibers in mouse and rat brain.The Journal of comparative neurology, 379 4
R. Naef, U. Suter (1999)
Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral NeuropathiesNeurobiology of Disease, 6
J. Colby, R. Nicholson, K. Dickson, W. Orfali, R. Naef, U. Suter, G. Snipes (2000)
PMP22 Carrying the Trembler or Trembler-J Mutation Is Intracellularly Retained in Myelinating Schwann CellsNeurobiology of Disease, 7
A. Gow, R. Lazzarini (1996)
A cellular mechanism governing the severity of Pelizaeus–Merzbacher diseaseNature Genetics, 13
R. Dermietzel, T. Hwang, D. Spray (1990)
The gap junction family: structure, function and chemistryAnatomy and Embryology, 182
L. Bone, S. Deschênes, R. Balice-Gordon, K. Fischbeck, S. Scherer (1997)
Connexin32 and X-linked Charcot–Marie–Tooth DiseaseNeurobiology of Disease, 4
J. Vanslyke, S. Deschênes, L. Musil (2000)
Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins.Molecular biology of the cell, 11 6
S. Deschênes, Jessica Walcott, Tamara Wexler, S. Scherer, K. Fischbeck (1997)
Altered Trafficking of Mutant Connexin32The Journal of Neuroscience, 17
R. Bruzzone, T. White, S. Scherer, K. Fischbeck, D. Paul (1994)
Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth diseaseNeuron, 13
R. Dermietzel, M. Farooq, J. Kessler, H. Althaus, E. Hertzberg, D. Spray (1997)
Oligodendrocytes express gap junction proteins connexin32 and connexin45Glia, 20
V. Tennyson (1970)
The Fine Structure of the Nervous System.JAMA Neurology, 22
G Lemke (1992)
Molecular neurobiology
J. Rash, T. Yasumura, F. Dudek, J. Nagy (2001)
Cell-Specific Expression of Connexins and Evidence of Restricted Gap Junctional Coupling between Glial Cells and between NeuronsThe Journal of Neuroscience, 21
A. Gow, C. Southwood, R. Lazzarini (1998)
Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher DiseaseThe Journal of Cell Biology, 140
S. Scherer, SM Deschenes, Yt Xu, J. Grinspan, K. Fischbeck, D. Paul (1995)
Connexin32 is a myelin-related protein in the PNS and CNS, 15
J. Brockes, K. Fields, M. Raff (1979)
Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerveBrain Research, 165
L. Notterpek, M. Ryan, A. Tobler, E. Shooter (1999)
PMP22 Accumulation in Aggresomes: Implications for CMT1A PathologyNeurobiology of Disease, 6
Hideyuki Kikyo, Tetsuo Furukawa (1999)
Creutzfeldt-Jakob-like syndrome induced by lithium, levomepromazine, and phenobarbitoneJournal of Neurology, Neurosurgery & Psychiatry, 66
G. Lin, J. Glass, S. Shumas, S. Scherer, K. Fischbeck (1999)
A Unique Mutation in Connexin32 Associated with Severe, Early Onset CMTX in a Heterozygous FemaleAnnals of the New York Academy of Sciences, 883
J. Laing, P. Tadros, E. Westphale, E. Beyer (1997)
Degradation of connexin43 gap junctions involves both the proteasome and the lysosome.Experimental cell research, 236 2
Y. Omori, Marc Mesnil, Hiroshi Yamasaki (1996)
Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.Molecular biology of the cell, 7 6
S. Porter, M. Clark, L. Glaser, R. Bunge (1986)
Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability, 6
M. Klugmann, M. Schwab, Anja Pühlhofer, Armin Schneider, F. Zimmermann, I. Griffiths, K. Nave (1997)
Assembly of CNS Myelin in the Absence of Proteolipid ProteinNeuron, 18
C. Elfgang, Reiner Eckert, Heua Lichtenberg-Frat, A. Butterweck, O. Traub, R. Klein, Dieter Hiilser, K. Willecke (1995)
Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cellsThe Journal of Cell Biology, 129
(1996)
Developmental defects of myelin
C. Thomson, P. Montague, M. Jung, K. Nave, I. Griffiths (1997)
Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variatioans in transport of PLP isoproteinsGlia, 20
R. Naef, K. Adlkofer, B. Lescher, U. Suter (1997)
Aberrant Protein Trafficking inTremblerSuggests a Disease Mechanism for Hereditary Human Peripheral NeuropathiesMolecular and Cellular Neuroscience, 9
C. Rabadán-Diehl, G. Dahl, R. Werner (1994)
A connexin‐32 mutation associated with Charcot‐Marie‐Tooth disease does not affect channel formation in oocytesFEBS Letters, 351
G Roussel, NM Neskovic, E Trifilieff, J‐C Artault, J‐L Nussbaum (1987)
Arrest of proteolipid protein through the Golgi apparatus in jimpy brain, 16
W Marques, MG Sweeney, NW Wood, SJ Wroe (1999)
Central nervous system involvement in a novel connexin 32 mutation affecting identical twins, 66
P. Kunzelmann, I. Blumcke, O. Traub, R. Dermietzel, K. Willecke (1997)
Coexpression of connexin45 and -32 in oligodendrocytes of rat brainJournal of Neurocytology, 26
C. Ressot, D. Gomès, A. Dautigny, D. Pham‐Dinh, R. Bruzzone (1998)
Connexin32 Mutations Associated with X-Linked Charcot–Marie–Tooth Disease Show Two Distinct Behaviors: Loss of Function and Altered Gating PropertiesThe Journal of Neuroscience, 18
R. Skoff (1995)
Programmed Cell Death in the Dysmyelinating MutantsBrain Pathology, 5
K‐A Nave, O Boespflug‐Tanguy (1996)
Developmental defects of myelin formation: from X‐linked mutations to human dysmyelinating diseases, 2
M. Panas, N. Kalfakis, C. Karadimas, D. Vassilopoulos (2001)
Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 geneNeurology, 57
G. Roussel, N. Neskovic, É. Trifilieff, J. Artault, J. Nussbaum (1987)
Arrest of proteolipid transport through the Golgi apparatus in Jimpy brainJournal of Neurocytology, 16
M. Panas, C. Karadimas, D. Avramopoulos, D. Vassilopoulos (1998)
Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutationsJournal of Neurology, Neurosurgery & Psychiatry, 65
P. Kim, P. Arvan (1998)
Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.Endocrine reviews, 19 2
T. Yoshimura, M. Satake, A. Ohnishi, Y. Tsutsumi, Y. Fujikura (1998)
Mutations of connexin32 in charcot‐marie‐tooth disease type X interfere with cell‐to‐cell communication but not cell proliferation and myelin‐specific gene expressionJournal of Neuroscience Research, 51
K. Stauffer (1995)
The Gap Junction Proteins β1-Connexin (Connexin-32) and β2-Connexin (Connexin-26) Can Form Heteromeric HemichannelsJournal of Biological Chemistry, 270
M. Marchionni, A. Goodearl, M. Chen, O. Bermingham-McDonogh, C. Kirk, M. Hendricks, F. Danehy, Don Misumi, J. Sudhalter, Kazumi Kobayashi, Diana Wroblewski, C. Lynch, M. Baldassare, I. Hiles, John Davis, John Davis, J. Hsuan, N. Totty, M. Otsu, R. McBurney, M. Waterfield, P. Stroobant, D. Gwynne (1993)
Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous systemNature, 362
A. Tobler, Ning Liu, L. Mueller, E. Shooter (2001)
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22Proceedings of the National Academy of Sciences of the United States of America, 99
R. Bruzzone, T. White, D. Paul (1996)
Connections with connexins: the molecular basis of direct intercellular signaling.European journal of biochemistry, 238 1
G. Nicholson, L. Yeung, A. Corbett (1998)
Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth familiesNeurology, 51
E. Arroyo, S. Scherer (2000)
On the molecular architecture of myelinated fibersHistochemistry and Cell Biology, 113
J. Bergoffen, S. Scherer, Sumei Wang, MO Scott, L. Bone, D. Paul, K. Chen, M. Lensch, P. Chance, K. Fischbeck (1993)
Connexin mutations in X-linked Charcot-Marie-Tooth disease.Science, 262 5142
R. Windoffer, Bernhard Beile, A. Leibold, Sabine Thomas, U. Wilhelm, R. Leube (2000)
Visualization of gap junction mobility in living cellsCell and Tissue Research, 299
Seunghoon Oh, Y. Ri, M. Bennett, E. Trexler, V. Verselis, T. Bargiello (1997)
Changes in Permeability Caused by Connexin 32 Mutations Underlie X-Linked Charcot-Marie-Tooth DiseaseNeuron, 19
Steven Scherer (1997)
Molecular Genetics of Demyelination: New Wrinkles on an Old MembraneNeuron, 18
D. D'urso, R. Prior, R. Greiner-Petter, A. Gabreëls-Festen, H. Müller (1998)
Overloaded Endoplasmic Reticulum–Golgi Compartments, a Possible Pathomechanism of Peripheral Neuropathies Caused by Mutations of the Peripheral Myelin Protein PMP22The Journal of Neuroscience, 18
JB Grinspan, M Coulaloglou, JS Beesley, D Carpio, SS Scherer (1998)
Maturation‐dependent apoptotic cell death of oligodendroglial cells in myelin‐deficient rats, 54
Matthias Falk (2000)
Connexin-specific distribution within gap junctions revealed in living cells.Journal of cell science, 113 ( Pt 22)
K. Nave, O. Boespflug-Tanguy (1996)
X-Linked Developmental Defects of Myelination: From Mouse Mutants to Human Genetic DiseasesThe Neuroscientist, 2
Both oligodendrocytes and myelinating Schwann cells express the gap junction protein connexin32 (Cx32). Mutations in the gene encoding Cx32 (GJB1) cause the X‐linked form of Charcot‐Marie‐Tooth disease (CMTX). Although most CMTX patients do not have clinical central nervous system (CNS) manifestations, subclinical evidence of CNS dysfunction is common. We investigated the cellular effects of a subgroup of GJB1/Cx32 mutations that have been reported to cause clinical CNS dysfunction. We hypothesized that these mutants have dominant‐negative effects on other connexins expressed by oligodendrocytes, specifically Cx45. We expressed these and other Cx32 mutants in communication‐incompetent as well as Cx45‐expressing HeLa cells, and analyzed the transfected cells by immunocytochemistry and immunoblotting. In communication‐incompetent cells, the mutants associated with CNS phenotypes failed to reach the cell membrane and were instead retained in the endoplasmic reticulum (A39V, T55I) or Golgi apparatus (M93V, R164Q, R183H), although rare gap junction plaques were found in cells expressing M93V or R183H. In HeLa cells stably expressing Cx45, these Cx32 mutants showed a similar expression pattern, and did not alter the pattern of Cx45 expression. These results indicate that Cx32 mutants that are associated with a CNS phenotype do not interact with Cx45, but may instead have other toxic effects in oligodendrocytes. © 2002 Wiley‐Liss, Inc.
Journal of Neuroscience Research – Wiley
Published: Jan 1, 2002
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.